Addressing funding gaps in blood cancer research
Dr. Gwen Nichols leads a discussion at 12:15 pm CST on July 13, 2026, on addressing funding gaps in blood.
The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.
Sharing clinical experience to support collective learning
Join SOHO Insider, the official media platform of the Society of Hematologic Oncology, for the inaugural Virtual Community Oncology Brown Bag Series, an informal lunchtime discussion program featuring community oncologists sharing real-world experiences from practice.
The program will be led and developed by Loretta J. Nastoupil, MD, our SOHO Insider Editorial leader in community oncology.
All sessions will no longer be held on Zoom. They will only be offered on-demand.
Dr. Gwen Nichols leads a discussion at 12:15 pm CST on July 13, 2026, on addressing funding gaps in blood.
Dr. Marin Xavier leads a discussion on integrating new evidence into everyday practice.
Dr. Hans Lee leads a discussion on increasing US representation in global clinical trials.
Dr. Shakira Grant leads a discussion on AI impacting pathology and treatment decisions.
Nina Shah, MD, global head of Multiple Myeloma Clinical Development and Strategy at AstraZeneca, will present "How Can Pharma Engage.
Live session held on February 11, 2026, from 2:00–2:30 PM CST with speaker Tara Graff presenting on "Implementing Bispecific Antibodies.
SOHO Insider is pleased to announce two new upcoming sessions in our Community Oncology Brown Bag Series, hosted by Loretta.
Live session held on March 18, 2026, from 2:30 – 3 pm CT with speaker Jeffrey Matous presenting on "Managing.
In this session from the SOHO Insider Community Oncology Brown Bag series, Dr. Krish Patel provides an overview on building.
Dr. Luke Fletcher leads a discussion at 11:30 am CST on May 15, 2026, on exploration of barriers and solutions.